Navigation Links
Cephalon Signs Investment Agreement to Fund ChemGenex Oncology Clinical Development Operations
Date:10/21/2010

FRAZER, Pa., Oct. 21 /PRNewswire/ -- Today, Cephalon, Inc. (Nasdaq: CEPH) announced the signing of a convertible note subscription agreement with ChemGenex Pharmaceuticals Limited (ASX: CXS), an Australian-based oncology focused biopharmaceutical company.  Under the terms of the agreement, Cephalon will provide up to A$15 million to ChemGenex in return for a note that is convertible at A$0.50 per share.  This funding will support ChemGenex operations, including clinical activities to complete a planned New Drug Application submission to the U.S. Food and Drug Administration for omacetaxine for the treatment of chronic myelogenous leukemia (CML) patients who have failed two or more tyrosine kinase inhibitor (TKIs).  Separately, Cephalon also entered into option agreements with two of ChemGenex's major shareholders, Stragen International N.V. and Merck Sante S.A.S.  Under those option agreements, Cephalon has the right to acquire up to 19.9 percent of ChemGenex's outstanding shares at A$0.70 per share.  

"Our deal with ChemGenex allows us to provide the necessary resources to support the completion of a clinical and regulatory pathway for omacetaxine for CML patients facing a critical unmet medical need," said Kevin Buchi, Chief Operating Officer at Cephalon.

Cephalon has the right to exercise the options before the later of March 31, 2011, and ten business days after receipt of certain clinical trial data and related analyses from ChemGenex (the "Exercise Period").  Cephalon has the right to convert the notes to ChemGenex shares at any time, subject to ChemGenex shareholder approval (to be sought by December 31, 2010) for conversion during the Exercise Period or if the options are exercised.  Cephalon will determine whether to exercise its rights under any or all of the agreements following receipt and review of the
'/>"/>

SOURCE Cephalon, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Cephalon Announces Positive Results from a Pivotal Study of FENTORA in Opioid-tolerant Patients with Non-cancer Breakthrough Pain
2. Cephalon Announces Positive Results from Its Pivotal Study of TREANDA in Patients with Non-Hodgkins Lymphoma
3. Journal of Clinical Oncology Publishes Study of Cephalon Medication TREANDA Plus Rituximab in Relapsed Non-Hodgkins Lymphoma
4. Cephalon Receives Complete Response Letter Regarding Request for Expanded FENTORA Label for Non-Cancer Breakthrough Pain
5. Cephalon Signs Option Agreement to Acquire Ception Therapeutics
6. Cephalon Announces Positive Results From a Phase Two Study of NUVIGIL in Bipolar Depression
7. Cephalon Announces Positive Results from a Phase Three Study of NUVIGIL in Jet Lag Disorder
8. Cephalon Provides Clinical Update on Lestaurtinib in Relapsed Acute Myelogenous Leukemia
9. Cephalon Submits NUVIGIL Supplemental New Drug Application for the Treatment of Excessive Sleepiness Associated with Jet Lag Disorder
10. Cephalon Announces that FDA Grants Priority Review of its Supplemental New Drug Application for NUVIGIL as a Treatment for Excessive Sleepiness Associated with Jet Lag Disorder
11. Cephalon Signs Option Agreement to Acquire BioAssets Development Corporation
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/19/2014)... 2014 Luoxis Diagnostics, Inc. , ... (NYSE MKT: AMPE), today announced an upcoming presentation ... the American Academy of Surgical Trauma (AAST) and ... Philadelphia, Pennsylvania that will be ... results from a recently completed five-year prospective clinical ...
(Date:8/18/2014)... Mass. and NAGOYA, Japan ... (NYSE: BSX ) and ASAHI INTECC (Securities ... and Nagoya Stock Exchange) have formalized plans to develop ... joint project focuses on creating a device intended to ... The FFR market is an emerging field in interventional ...
(Date:8/18/2014)... , Aug. 18, 2014 Reportlinker.com ... is available in its catalogue: ... http://www.reportlinker.com/p01597713/Bioseparation-Systems-for-Global-Biopharmaceutical-Markets.html ... into three types: chromatography, membranes/filters and centrifuges. ... increasing and fueling growth of the global ...
Breaking Medicine Technology:Luoxis Announces Presentation of Positive Clinical Findings from Five-Year Clinical Study of Traumatic Brain Injury and Oxidation-Reduction Potential at 2014 American Academy of Surgical Trauma Meeting 2Luoxis Announces Presentation of Positive Clinical Findings from Five-Year Clinical Study of Traumatic Brain Injury and Oxidation-Reduction Potential at 2014 American Academy of Surgical Trauma Meeting 3Boston Scientific and ASAHI INTECC Announce Joint Development and Manufacturing Programs 2Boston Scientific and ASAHI INTECC Announce Joint Development and Manufacturing Programs 3Boston Scientific and ASAHI INTECC Announce Joint Development and Manufacturing Programs 4Bioseparation Systems for Global Biopharmaceutical Markets 2Bioseparation Systems for Global Biopharmaceutical Markets 3Bioseparation Systems for Global Biopharmaceutical Markets 4Bioseparation Systems for Global Biopharmaceutical Markets 5Bioseparation Systems for Global Biopharmaceutical Markets 6Bioseparation Systems for Global Biopharmaceutical Markets 7Bioseparation Systems for Global Biopharmaceutical Markets 8Bioseparation Systems for Global Biopharmaceutical Markets 9Bioseparation Systems for Global Biopharmaceutical Markets 10Bioseparation Systems for Global Biopharmaceutical Markets 11Bioseparation Systems for Global Biopharmaceutical Markets 12
... Anthem Blue Cross and Blue Shield in ... transparency initiative beyond major metro areas into the ... and everywhere in between can now access Anthem ... cost information for 59 specific medical procedures performed ...
... 2010 STAAR Surgical Company (Nasdaq: STAA ... invasive ophthalmic products, today reported results for the third ... grew 6% to $13.2 million reflecting core product (IOLs ... decrease in defocused product revenue as compared to the ...
Cached Medicine Technology:Anthem Blue Cross Blue Shield Introduces Cost Disclosure Tool Throughout Colorado 2Anthem Blue Cross Blue Shield Introduces Cost Disclosure Tool Throughout Colorado 3STAAR Surgical Reports Continued Double Digit Core Revenue Growth 2STAAR Surgical Reports Continued Double Digit Core Revenue Growth 3STAAR Surgical Reports Continued Double Digit Core Revenue Growth 4STAAR Surgical Reports Continued Double Digit Core Revenue Growth 5STAAR Surgical Reports Continued Double Digit Core Revenue Growth 6STAAR Surgical Reports Continued Double Digit Core Revenue Growth 7STAAR Surgical Reports Continued Double Digit Core Revenue Growth 8STAAR Surgical Reports Continued Double Digit Core Revenue Growth 9STAAR Surgical Reports Continued Double Digit Core Revenue Growth 10STAAR Surgical Reports Continued Double Digit Core Revenue Growth 11STAAR Surgical Reports Continued Double Digit Core Revenue Growth 12STAAR Surgical Reports Continued Double Digit Core Revenue Growth 13STAAR Surgical Reports Continued Double Digit Core Revenue Growth 14STAAR Surgical Reports Continued Double Digit Core Revenue Growth 15STAAR Surgical Reports Continued Double Digit Core Revenue Growth 16STAAR Surgical Reports Continued Double Digit Core Revenue Growth 17
(Date:8/19/2014)... Kentucky Markey Cancer Center researchers will provide a simple, free ... require testing for a genetic mutation. , Gliomas a ... are the most common and deadly form of brain ... brain cancer cases. In some of these cases, patients have ... mutation and patients who have this tend to survive ...
(Date:8/19/2014)... Hartford/VA Scholars Program has selected three geriatric ... provides career development and mentorship for projects that ... veterans, but for all older adults. , The ... physical activity among veterans, transitions from VA nursing ... disorder in older veterans. The Hartford/VA Geriatric Scholars ...
(Date:8/19/2014)... 2014 United Benefit Advisors (UBA), ... is pleased to announce Sihle Insurance Group as ... provides a single solution for insurance, financial services, ... needs. With a focus on commercial and personal ... insurance solutions, and payroll services, they are able ...
(Date:8/19/2014)... Utah (PRWEB) August 19, 2014 ... Solution, published a new guide on compliance and ... Benefits, small businesses want to offer employee health ... insurance is unsustainable. Additionally, there are new advantages ... guaranteed-issue, and lower costs. , The new ...
(Date:8/19/2014)... Respected Dallas Plastic Surgeon ... nationwide to feature one of the most advanced ... UltraShape. UltraShape uses ultrasound waves to selectively breakdown ... , The UltraShape System, by Syneron Medical, is ... targets subcutaneous fat, while keeping the surrounding skin ...
Breaking Medicine News(10 mins):Health News:United Benefit Advisors Welcomes New Partner Firm Sihle Insurance Group 2Health News:United Benefit Advisors Welcomes New Partner Firm Sihle Insurance Group 3Health News:Dallas Plastic Surgeon Dr. Benjamin Bassichis is Among the First to Offer UltraShape for Non-Surgical Liposuction 2Health News:Dallas Plastic Surgeon Dr. Benjamin Bassichis is Among the First to Offer UltraShape for Non-Surgical Liposuction 3
... ... QT Beat-to-Beat(sm) Studies , ... Rochester, N.Y. (PRWEB) March 11, 2010 -- iCardiac Technologies, Inc., a leader in ... pharmaceutical company has awarded iCardiac a comprehensive cardiac safety study. iCardiac will provide ...
... ... last three years fundraising to send life-saving bed nets to families in ... grassroots campaign to prevent malaria in Africa, the leading killer of children ... and plans to raise $50,000 by the time he starts college. This ...
... ... Plunge, a benefit for the Special Olympics. , ... Salt Lake City, UT (PRWEB) March 11, 2010 -- Bullfrog International, makers ... Pelican Bay Marina in Saratoga Springs, Utah and hosted by the Saratoga Police Department. Bullfrog ...
... ... from a national workshop have been released to address deep-vein thrombosis (DVT) and pulmonary ... each year. , ... Washington, D.C. (PRWEB) March 11, 2010 -- Three critical recommendations from a national workshop ...
... , WEDNESDAY, March 10 (HealthDay News) -- By analyzing ... U.S. scientists have identified gene mutations associated with the ... the limbs, hands and feet. , The study, published ... of Medicine , involved sequencing the complete genome of ...
... infestations, study shows, , WEDNESDAY, March 10 (HealthDay News)-- ... ivermectin is more effective than the standard treatment, the ... published in the March 11 issue of the ... percent of those treated with ivermectin were lice-free after ...
Cached Medicine News:Health News:Top 10 Pharmaceutical Company Awards Comprehensive Cardiac Safety Study to iCardiac 2Health News:High School Student's College Prerequisite: Save Five Thousand Lives in Africa. Teen Supports Nothing But Nets in Malaria Fight 2Health News:High School Student's College Prerequisite: Save Five Thousand Lives in Africa. Teen Supports Nothing But Nets in Malaria Fight 3Health News:Hot Tub Company Helps Swimmers Thaw and Supports Special Olympics 2Health News:Critical Recommendations Unveiled to Respond to National Public Health Crisis: Deep-Vein Thrombosis and Pulmonary Embolism 2Health News:Critical Recommendations Unveiled to Respond to National Public Health Crisis: Deep-Vein Thrombosis and Pulmonary Embolism 3Health News:Critical Recommendations Unveiled to Respond to National Public Health Crisis: Deep-Vein Thrombosis and Pulmonary Embolism 4Health News:Critical Recommendations Unveiled to Respond to National Public Health Crisis: Deep-Vein Thrombosis and Pulmonary Embolism 5Health News:Gene Mutations Identified for Charcot-Marie-Tooth Syndrome 2Health News:For Tough Head Lice, Pill Tops Lotion 2Health News:For Tough Head Lice, Pill Tops Lotion 3
... The Awaya stereo test was developed to ... Awaya Stereo test employs the more reliable ... eye. It is not dependent on polarizing spectacles ... first target is an attractive image of a ...
... is designed to assist patients with red-green color ... filter cuts off wavelengths shorter than 582 nm ... of their most difficult color distinctions. A color ... determine whether a color is in the longer ...
Features a twist-on backswitch, with a diffused, cobalt blue light beam....
Heavy duty, all purpose illuminator available in blue and green. Unique Clip Switch automatically turns off when returned to pocket. Pre-focused lens tip Heine XHL Halogen bulb for bright, concentra...
Medicine Products: